Gleevec Tablet
Product Images NDC 0078-0401

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gleevec (NDC 0078-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Imatinib Structural Formula (Gleevec 01)

Imatinib Structural Formula (Gleevec 01)
FDA Label Image

Figure 1 Progression Free Survival (itt Principle) (Gleevec 02)

Figure 1 Progression Free Survival (itt Principle) (Gleevec 02)
FDA Label Image

Figure 2 Time To Progression To Ap Or Bc (itt Principle) (Gleevec 03)

Figure 2 Time To Progression To Ap Or Bc (itt Principle) (Gleevec 03)
FDA Label Image

Figure 3: Study 1 Recurrence-free Survival (itt Population) (Gleevec 04)

Figure 3: Study 1 Recurrence-free Survival (itt Population) (Gleevec 04)
FDA Label Image

Figure 4: Study 2 Recurrence-free Survival (itt Population) (Gleevec 05)

Figure 4: Study 2 Recurrence-free Survival (itt Population) (Gleevec 05)
FDA Label Image

Figure 5: Study 2 Overall Survival (itt Population) (Gleevec 06)

Figure 5: Study 2 Overall Survival (itt Population) (Gleevec 06)
FDA Label Image

Principal Display Panel – Package Label – 100 mg Tablets (Gleevec 07)

Principal Display Panel – Package Label – 100 mg Tablets (Gleevec 07)
This appears to be a mix of random letters, numbers, and symbols, with some mentioning of tablets containing imatirib mesylate. As a result, a useful description cannot be generated. It is likely that the text was not accurately recognized by the tool or sections of a document were scanned instead of an intended page.*
FDA Label Image

Principal Display Panel – Package Label – 400 mg Tablets (Gleevec 08)

Principal Display Panel – Package Label – 400 mg Tablets (Gleevec 08)
This is the description for the medicine Gleevec. Gleevec is a medicine containing Imatinib Mesylate used in the treatment of cancer. Each tablet contains 400 mg of the active ingredient. The product is prescription-only. It should be stored in USP-controlled room temperature and protected from moisture. The text also contains manufacturing information, dosage instructions, and safety information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.